Ascl2 and 11p15.5 amplification in colorectal cancer
We read with interest the recent article by Stange et al 1 describing gain of 11p or 11p15.5 in approximately one-quarter of colorectal cancer liver metastases compared with mat...
We read with interest the recent article by Stange et al 1 describing gain of 11p or 11p15.5 in approximately one-quarter of colorectal cancer liver metastases compared with mat...
Activating mutations in KRAS and BRAF are found in more than 30% of all human tumours and 40% of melanoma, respectively, thus targeting this pathway could have broad therapeutic...
h-index: Number of publications with at least h citations each.